$EXLS

Bhalla Vikas sold $382K of EXLS

Bhalla Vikas (President of EXL) sold 10,000 shares of ExlService Holdings, Inc. (EXLS) at $38.17 ($0.38M total) on 2026-09-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Bhalla Vikas
Published Sep 3, 2026, 8:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 3, 2026, 8:08 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$EXLS
Neutral
medium confidence
Mentioned
$EXLS
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$EXLSNeutralLow
01

Why it matters

The transaction is a primary disclosure but modest in scale, offering limited trading edge.

02

Market read

Small insider sale; unlikely to move the stock significantly.

03

What to watch

Potential upcoming earnings or strategic announcements that may contextualize the sale.

Relevance 3/10Novelty 4/10Timing: today

Background

Form 4 filing discloses insider transactions required by SEC regulations.

Company-level read

Ticker impact

$EXLSNeutralMedium confidence
Context

President Vikas Bhalla sold 10,000 shares for $381,700 via a 10b5‑1 plan.

Expected impact

Minor downward pressure, likely within normal volatility range.

Evidence & confidence

The sale size ($382K) is modest relative to market cap; no other material news accompanies it.

Market effects

No immediate sector impact; insider sale is company‑specific.

Limited to US equity market participants tracking EXL.

Low; the filing does not affect broader market dynamics.

Counterpoint

The sale could be a routine liquidity move, not a negative signal.

Key entities

  • ExlService Holdings, Inc.

    US‑listed provider of data‑driven business process services.

  • Vikas Bhalla

    President of EXL, reporting a sale of 10,000 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CSGPMed

Q2 Earnings Highs And Lows: CoStar (NASDAQ:CSGP) Vs The Rest Of The Data & Business Process Services Stocks

CoStar (CSGP) reported Q2 revenue of $925M, up 18.4% YoY, meeting expectations but delivering the weakest guidance among peers. EXL (EXLS) outperformed with $594.8M revenue, up 15.6% YoY, and raised full-year guidance. Equifax (EFX) and TransUnion (TRU) also reported, with TRU raising guidance. The sector saw mixed results, with revenues 1% above consensus but next quarter's guidance 1.3% below. Stocks are up 7.8% on average since earnings.

$EXLSMed

ExlService Holdings (EXLS) Is Up 7.8% After Securing New US$1 Billion Credit Facility - What's Changed

ExlService Holdings (EXLS) stock rose 7.8% after securing a new $1 billion credit facility, replacing its prior $600 million facility. The new agreement includes a $600 million revolving credit line and a $400 million term loan maturing in 2031. The company plans to use the funds for acquisitions and AI investments, aiming for $3.2 billion revenue and $374.5 million earnings by 2029.

$EXLSMedAI 8/10

ExlService (EXL) Soars 17.88%, Wins Hedge Fund Confidence

ExlService Holdings (EXLS) rose 17.88% to close at $35.99 after Q2 results and a positive outlook. Q2 revenue was $594.76 million, up 15.6% y/y, with net income $64.5 million. FY26 guidance: $2.39B to $2.415B revenue and adjusted EPS $2.25 to $2.29. Needham raised its price target to $45 from $40.

$EXLSMedAI 8/10

EXL (EXLS) Shares Skyrocket, What You Need To Know

ExlService Holdings (EXLS) shares rose 17.9% after the company reported quarter 2026 results that beat expectations and raised full-year guidance. Quarterly revenue grew 15.6% to $594.8M and adjusted EPS rose 20.4% to $0.59. Management lifted full-year revenue guidance midpoint to $2.40B and adjusted EPS to $2.27.

$EXLSMedAI 8/10

EXL (NASDAQ:EXLS) Surprises With Strong Q2 CY2026, Full

ExlService Holdings (NASDAQ:EXLS) reported Q2 CY2026 revenue of $594.8 million, up 15.6% year on year, beating Wall Street estimates. Full-year revenue guidance was $2.40 billion at the midpoint, 3.1% above analysts’ expectations. Non-GAAP EPS was $0.59, 7.8% above consensus. The stock rose 2.3% to $31.25 after the release.